NasdaqGS - Nasdaq Real Time Price
USD
Vertex Pharmaceuticals Incorporated (VRTX)
559.57
+19.57
(+3.62%)
As of 3:45:32 PM EDT. Market Open.
Trade VRTX on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreNews headlines
Powered by Yahoo ScoutVertex Pharmaceuticals is approaching its November 2 third-quarter earnings reportwith expectations for double-digit revenue growth. Investors are focused on whether newer products, including Casgevy and Journavx, can reduce the company’s dependence on cystic fibrosis treatments. Positive late-stage povetacicept results also support Vertex’s expansion into kidney disease.
